Suchergebnisse - "Tikhonova, Irina A"

PubPharm (19)

1

Anionic Complexes of the Perfluorinated Three‐Mercury Anticrown ( o,o’‐C6 F4 C6 F4 Hg)3. Dependence of the Anion Coordination Type on Counter‐Cation in Case of Chloride and Bromide Anions

enthalten in: ChemistrySelect | 2022

von Gribanyov, D. | Tugashov, K. | Dolgushin, F. | +4

2

Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis : a systematic review and economic evaluation

enthalten in: Health technology assessment (Winchester, England) | 2021

von Tikhonova, I. | Yang, H. | Bello, S. | +9

3

Coordination Chemistry of Anticrowns. Synthesis and Structures of Complexes of the Perfluorinated Three‐Mercury Anticrown ( o‐C6 F4 Hg)3 with Monohalogenobenzenes

enthalten in: European Journal of Inorganic Chemistry | 2019

von Tugashov, K. | Yunusov, S. | Kalyuzhnaya, E. | +6

4

Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England

enthalten in: PharmacoEconomics | 2018

von Tikhonova, I. | Huxley, N. | Snowsill, T. | +4

5

Correction to : Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal

enthalten in: PharmacoEconomics | 2018

von Tikhonova, I. | Jones-Hughes, T. | Dunham, J. | +4

ErratumFor: Pharmacoeconomics. 2018 Jan;36(1):39-49. - PMID 28914440

6

Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England

enthalten in: PharmacoEconomics | 2018

von Tikhonova, I. | Huxley, N. | Snowsill, T. | +4

7

Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England

enthalten in: PharmacoEconomics | 2018

von Tikhonova, I. | Huxley, N. | Snowsill, T. | +4

8

Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England

enthalten in: PharmacoEconomics | 2018

von Tikhonova, I. | Huxley, N. | Snowsill, T. | +4

9

Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal

enthalten in: PharmacoEconomics | 2018

von Tikhonova, I. | Jones-Hughes, T. | Dunham, J. | +4

10

Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal

enthalten in: PharmacoEconomics | 2018

von Tikhonova, I. | Jones-Hughes, T. | Dunham, J. | +4